Daiwa Securities Group Inc. Global Blood Therapeutics, Inc. Transaction History

Daiwa Securities Group Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	BUY	$25.48 - $37.34 $2,497 - $3,659	98 Added 84.48%	214 $5,000
Q4 2020 Feb 04, 2021	SELL	$37.65 - $63.77 $8,734 - $14,794	-232 Reduced 66.67%	116 $5,000
Q3 2020 Nov 02, 2020	BUY	$52.76 - $74.49 $422 - $595	8 Added 2.35%	348 $19,000
Q4 2019 Jan 31, 2020	SELL	$45.7 - $81.86 $1,919 - $3,438	-42 Reduced 10.99%	340 $27,000
Q3 2019 Nov 04, 2019	BUY	$45.35 - $57.91 $1,088 - $1,389	24 Added 6.7%	382 $19,000
Q1 2019 Apr 26, 2019	BUY	$39.99 - $53.48 $4,678 - $6,257	117 Added 48.55%	358 $19,000
Q1 2018 May 02, 2018	BUY	$39.6 - $65.9 $9,543 - $15,881	241 New	241 $12,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.